Showing results (241-250 of 343) with videos related to

Sort By:
Pageof 35
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2024
Penetrance, cancer incidence and survival in HFE haemochromatosis-A population-based cohort studyBenedikt Schaefer, Lorenz M Pammer, Bernhard Pfeifer, et al.
Gut|May 23, 2024
Association between primary hypothyroidism and metabolic dysfunction-associated steatotic liver disease: an updated meta-analysisAlessandro Mantovani, Alessandro Csermely, Josh Bilson, et al.
Atherosclerosis|April 13, 2018
Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular diseaseClaudia Ress, Mariya Paulweber, Georg Goebel, et al.
Annals of Internal Medicine|November 5, 2019
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort StudyGianluca Ianiro, Rita Murri, Giusi Desirè Sciumè, et al.
Cell|September 9, 2008
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel diseaseArthur Kaser, Ann-Hwee Lee, Andre Franke, et al.
Iscience|November 14, 2022
Ultra-rapid rollout vaccination with BNT162b2 to reduce SARS-CoV-2 infections in the general populationLena Tschiderer, Lisa Seekircher, Lukas Richter, et al.
Nature Communications|August 14, 2025
Dysregulation of GTPase-activating protein-binding protein1 in the pathogenesis of metabolic dysfunction-associated steatotic liver diseaseQinqin Ouyang, Jiaqi Su, Yixuan Li, et al.
Rheumatology (Oxford, England)|January 27, 2011
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic studyJochen Zwerina, Christian Bach, Davide Martorana, et al.
Immunity|January 25, 2011
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathwaysManfred Nairz, Andrea Schroll, Alexander R Moschen, et al.
Frontiers in Endocrinology|April 13, 2026
Escherichia-Shigella expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiencyErika Kvalem Soto, Valeria Wagner, Julia Engl, et al.
Pageof 35